Dr Rachel Delahunty is an early career medical oncologist with a special interest in gynaecological oncology and translational and clinical research.

She graduated from Monash University before completing advanced training in medical oncology in Melbourne and was awarded Fellowship to The Royal Australian College of Physicians in January 2016. Following this she worked as The Clinical Trials Fellow at Eastern Health, overseeing the conduct of phase 1-phase 3 clinical trials and in 2017 she commenced a Doctor of Philosophy (PhD) in the Bowtell laboratory  at The Peter MacCallum  Cancer Centre.

Dr Delahunty will be running ‘TRACEBACK’, a clinical trial aimed to improve the detection of pathogenic BRCA1/2 mutations in patients with a history of ovarian cancer with the aim of reducing the number of BRCA1/2 related cancers  in Australia.

In addition she will lead a pilot translational research project of ctDNA in endometrial cancer which she will run alongside ongoing clinical work in medical oncology.

View Dr Rachel Delahunty’s ovarian cancer symposium presentation.

Identification of women carrying germline BRCA1/2 mutations through a retrospective analysis of patients diagnosed with high grade serous ovarian cancer.’